Non-typhoidal salmonella in children: Microbiology, epidemiology and treatment

Advances in Experimental Medicine and Biology

Volumn 764, Issue , 2013, Pages 13-26

  Haeusler, Gabrielle M ^a   Curtis, Nigel ^a,b,c  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; AMPICILLIN; AZITHROMYCIN; CEPHALOSPORIN; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; MACROLIDE; NALIDIXIC ACID; NEOMYCIN; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE;

ACUTE GASTROENTERITIS; ANTIBIOTIC RESISTANCE; ARTHROPATHY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; BACTERIUM CARRIER; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; CLINICAL FEATURE; DISEASE CLASSIFICATION; DISK DIFFUSION; DRUG SAFETY; FOOD CONTAMINATION; FOOD CONTROL; GRAM NEGATIVE SEPSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; INFECTION RISK; INFECTION SENSITIVITY; INFECTIOUS DIARRHEA; MALARIA; MALNUTRITION; MUSCULOSKELETAL DISEASE; NONHUMAN; PATHOGENESIS; PREGNANCY; PREGNANCY OUTCOME; PRIORITY JOURNAL; SALMONELLA PARATYPHI; SALMONELLA TYPHI; SALMONELLOSIS; SPECIES COMPARISON;

EID: 84873573057     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4614-4726-9_2     Document Type: Article

References (95)

1. Grimont PAD, Weill F (2007) Antigenic Formulae of the Salmonella Serovars. 9th edn. Institut Pasteur, Paris
2. Tindall BJ, Grimont PAD, Garrity GM, Euzeby JP (2005) Nomenclature and taxonomy of the genus Salmonella. Int J Syst Evol Microbiol 55:521-5244
3. Nataro JP, Bopp CA, Fields PI, Kaper JB, Strockbine NA (2011) Escherichia, Shigella, and Salmonella. In: Versalovic J, Carroll KC, Funke G, Jorgensen JH, Landry ML, Warnock DW (eds.). Manual of Clinical Microbiology, 10th edn. ASM, Washington, DC, p 603-6266
4. Pegues DA, Miller SI (2010) Salmonella Species, including Salmonella Typhi. In: Mandell GL, Bennett JE, Dolin R (eds). Mandell, Douglas and Bennett's Principles and Practices of Infectious Diseases, 7th edn. Elsevier, Philadelphia, p 2887-29033
5. Brenner FW, Villar RG, Angulo FJ, Tauxe R, Swaminathan B (2000) Salmonella nomenclature. J Clin Microbiol 38:2465-24677
6. Majowicz SE, Musto J, Scallan E, Angulo FJ, Kirk M, O'Brien SJ et al (2010) The global burden of nontyphoidal Salmonella gastroenteritis. Clin Infect Dis 50:882-8899
7. Vieira A, Jensen AR, Pires SM, Karlsmose S, Wegener HC, Wong DLF (2009) WHO Global Foodborne Infections Network Country Databank - A resource to link human and non-human sources of Salmonella. Int Soc Vet Epidemiol Econ 643:512-5177
8. Braden CR (2006) Salmonella enterica serotype Enteritidis and eggs: A national epidemic in the United States. Clin Infect Dis 43:512-5177
9. Hohmann EL (2001) Nontyphoidal salmonellosis. Clin Infect Dis 32:263-2699
10. Mermin J, Hutwagner L, Vugia D, Shallow S, Daily P, Bender J et al (2004) Reptiles, amphibians, and human Salmonella infection: A populationbased, case-control study. Clin Infect Dis 38(Suppl 3):S253-2611
11. Weikel CS, Guerrant RL (1985) Nosocomial salmonellosis. Infection Control: IC 6:218-2200
12. AAP (2006) Salmonella Infections. In: Pickering LK, Baker CJ, Kimberlin DW, Long SS (eds). Red Book: 2009 Report of the Commitee on Infectious Diseases, 28th edn. American Academy of Pediatrics, Elk Grove Village, p 584-5888
13. Blaser MJ, Newman LS (1982) A review of human salmonellosis: I. Infective dose. Rev Infect Dis 4:1096-11066
14. Seals JE, Parrott PL, McGowan JE, Jr., Feldman RA (1983) Nursery salmonellosis: Delayed recognition due to unusually long incubation period. Infection Control: IC 4:205-2088
15. Garcia-del Portillo F (2001) Salmonella intracellular proliferation: Where, when and how? Microbes Infect 3:1305-3111
16. Dougan G, John V, Palmer S, Mastroeni P (2011) Immunity to salmonellosis. Immunol Rev 240:196-2100
17. Gondwea EN, Molyneuxa ME, Goodallc M, Graham SM, Mastroenig P, Draysonc MT et al (2010) Importance of antibody and complement for oxidative burst and killing of invasive nontyphoidal Salmonella by blood cells in Africans. PNAS 107:3070-30755
18. MacLennan CA, Gondwe EN, Msefula CL, Kingsley RA, Thomson NR, White SA et al (2008) The neglected role of antibody in protection against nontyphoidal salmonella bacteremia in African children. J Clin Invest 118:1553-15622
19. Tennant SM, Hartland EL, Phumoonna T, Lyras D, Rood JI, Robins-Browne RM et al (2008) Influence of gastric acid on susceptibility to infection with ingested bacterial pathogens. Infect Immun 76:639-6455
20. Buchin PJ, Andriole VT, Spiro HM (1980) Salmonella infections and hypochlorhydria. J Clin Gastroenterol 2:133-1388
21. O'Ryan ML, Nataro JP, Cleary TG (2011) Microorganisms Responsible for Neonatal Diarrhea. In: Remington JS, Klein JO, Wilson CB, Nizet V, Maldonado Y (eds). Remington: Infectious Diseases of the Fetus and Newborn, 7th edn. Elsevier, Philadelphia, p. 359-4188
22. Moir S, Fauci AS (2010) Immunology. Salmonella susceptibility. Science 328:439-440 (New York, NY) \\
23. Celum CL, Chaisson RE, Rutherford GW, Barnhart JL, Echenberg DF (1987) Incidence of salmonellosis in patients with AIDS. J Infect Dis 156:998-10022
24. Ramos JM, Garcia-Corbeira P, Aguado JM, Arjona R, Ales JM, Soriano F (1994) Clinical significance of primary vs. secondary bacteremia due to nontyphoid Salmonella in patients without AIDS. Clin Infect Dis 19:777-7800
25. Abruzzi A, Fried B (2011) Coinfection of Schistosoma (Trematoda) with bacteria, protozoa and helminths. Adv Parasitol 77:1-855
26. Jertborn M, Haglind P, Iwarson S, Svennerholm AM (1990) Estimation of symptomatic and asymptomatic Salmonella infections. Scand J Infect Dis 22:451-4555
27. Mandal BK, Brennand J (1988) Bacteraemia in salmonellosis: A 15 year retrospective study from a regional infectious diseases unit. BMJ 297:1242-1243 (Clinical research ed) \\
28. Jones TF, Ingram LA, Cieslak PR, Vugia DJ, Tobin-D'Angelo M, Hurd S et al (2008) Salmonellosis outcomes differ substantially by serotype. J Infect Dis 198:109-1144
29. Vugia DJ, Samuel M, Farley MM, Marcus R, Shiferaw B, Shallow S et al (2004) Invasive Salmonella infections in the United States, FoodNet, 1996-1999: Incidence, serotype distribution, and outcome. Clin Infect Dis 38(Suppl 3):S149-1566
30. Gordon MA (2011) Invasive nontyphoidal Salmonella disease: Epidemiology, pathogenesis and diagnosis. Curr Opin Infect Dis 24:484-4899
31. Graham SM (2010) Nontyphoidal salmonellosis in Africa. Curr Opin Infect Dis 23:409-4144
32. Scott AJ, Berkley JA, Mwangi I, Ochola L, Uyoga S, Macharia A et al (2011) Relation between falciparum malaria and bacteraemia in Kenyan children: A population-based, case-control study and a longitudinal study. Lancet 378:1316-13233
33. Schutze GE, Schutze SE, Kirby RS (1997) Extraintestinal salmonellosis in a children's hospital. Pediatr Infect Dis J 16:482-4855
34. Owusu-Ofori A, Scheld WM (2003) Treatment of Salmonella meningitis: Two case reports and a review of the literature. Int J Infect Dis 7:53-600
35. Sirinavin S, Jayanetra P, Lolekha S, Layangkul T (1988) Predictors for extraintestinal infection in Salmonella enteritis in Thailand. Pediatr Infect Dis J 7:44-488
36. Galanakis E, Bitsori M, Maraki S, Giannakopoulou C, Samonis G, Tselentis Y (2007) Invasive non-typhoidal salmonellosis in immunocompetent infants and children. Int J Infect Dis 11:36-399
37. Zaidi E, Bachur R, Harper M (1999) Non-typhi Salmonella bacteremia in children. Pediatr Infect Dis J 18:1073-10777
38. Katz BZ, Shapiro ED (1986) Predictors of persistently positive blood cultures in children with "occult" Salmonella bacteremia. Pediatr Infect Dis 5:713-7144
39. Ramos JM, Aguado JM, Garcia-Corbeira P, Ales JM, Soriano F (1996) Clinical spectrum of urinary tract infections due on nontyphoidal Salmonella species. Clin Infect Dis 23:388-3900
40. Gasem MH, Keuter M, Dolmans WMV, Van Der Ven-Jongekrijg J, Djokomoeljanto R, Van Der Meer JWM (2003) Persistence of Salmonellae in blood and bone marrow: Randomized controlled trial comparing ciprofloxacin and chloramphenicol treatments against enteric fever. Antimicrob Agents Chemother 47:1727-17311
41. Ternhag A, Torner A, Svensson A, Ekdahl K, Giesecke J (2008) Short-and long-term effects of bacterial gastrointestinal infections. Emerg Infect Dis 14:143-1488
42. Arnedo-Pena A, Beltran-Fabregat J, Vila-Pastor B, Tirado-Balaguer MD, Herrero-Carot C, Bellido-Blasco JB et al (2010) Reactive arthritis and other musculoskeletal sequelae following an outbreak of Salmonella hadar in Castellon, Spain. J Rheumatol 37:1735-17422
43. Buchwald DS, Blaser MJ (1984) A review of human salmonellosis: II. Duration of excretion following infection with nontyphi Salmonella. Rev Infect Dis 6:345-3566
44. Corrado ML, DuPont HL, Cooperstock M, Fekety R, Murray DM (1992) Evaluation of new anti-infective drugs for the treatment of chronic carriage of Salmonella. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis 15(Suppl 1):S259-2622
45. Gilbert DN, Moellering RC, Eliopoulis GM, Saag MS (2011) The Sanford Guide to Antimicrobial Therapy, 41st edn
46. Ingham B, Brentnall DW, Dale EA, McFadzean JA (1977) Arthropathy induced by antibacterial fused N-alkyl-4-pyridone-3-carboxylic acids. Toxicol Lett 1:21-266
47. Adefurin A, Sammons H, Jacqz-Aigrain E, Choonara I (2011) Ciprofloxacin safety in paediatrics: A systematic review. Arch Dis Child 96:874-8800
48. Pickering LK (2009) Approach to Patients with Gastrointestinal Tract Infections and Food Poisoning. In: Feigin RD, Cherry J, Demmler-Harrison G, Kaplan S (eds). Textbook of Pediatric Infectious Diseases. Elsevier, Philadelphia, p 621-6533
49. Graham SM (2008) Salmonellosis. In: McIntosh N, Helms P, Smyth R, Logan S (eds). Forfar and Arneil's Textbook of Pediatrics, 7th edn. Elsevier, Philadelphia, p 1246-12499
50. Isaacs D (2007) Gastrointestinal infections. In: Elliot E, Gilbert R, Moyer V, Pichichero M (eds). Evidence-based Pediatric Infectious Diseases. Blackwell Publishing, United Kingdom, p 74-1011
51. Reller ME (2009) Salmonella Species. In: Long SS, Pickering LK, Prober C (eds). Principles and Practice of Pediatric Infectious Diseases, 3rd edn. Elsevier, Philadelphia, p 812-8177
52. Bhutta ZA (2011) Salmonella. In: Kliegman RM, Stanton BMD, St Geme J, Schor N, Behrman RE (eds). Nelson Textbook of Pediatrics, 19th edn. Elsevier, Philadelphia, p 948-9588
53. Pickering LK (2006) Salmonella Infections. In: McMillan JA, Feigin RD, DeAngelis D, Jones MD (eds). Oski's Pediatrics: Principles and Practice, 4th edn. Lippincott Williams and Wilkins, Philadelphia, p 1112-11166
54. Pavia AT (2011) Salmonella, Shigella, and Escherichia coli. In: Rudolph C, Rudolph A, Lister G, First L, Gershon A (eds). Rudolph's Pediatrics, 22nd edn. McGraw Hill, New York
55. Guerrant RL, Van Gilder T, Steiner TS, Thielman NM, Slutsker L, Tauxe RV et al (2001) Practice guidelines for the management of infectious diarrhea. Clin Infect Dis 32:331-3511
56. (2009) Hohmann EL (2012) Approach to the patient with nontyphoidal Salmonella in a stool culture. In: Baron EL (ed). UpToDate, Waltham
57. Sirinavin S, Garner P (2000) Antibiotics for treating salmonella gut infections. Cochrane Database Syst Rev (Online):CD0011677
58. Garcia de Olarte D, Hugo TS, Nancy AO, Nelson JD, Haltalin KC (1974) Treatment of Diarrhea in Malnourished Infants and Children: A Double-Blind Study Comparing Ampicillin and Placebo. Am J Dis Child 127:379-3888
59. Nelson JD, Kusmiesz H, Jackson LH, Woodman E (1980) Treatment of Salmonella gastroenteritis with ampicillin, amoxicillin, or placebo. Pediatrics 65:1125-11300
60. Haltalin KC, Kusmiesz HT, Hinton LV, Nelson JD (1972) Treatment of Acute Diarrhea in Outpatients: Double-Blind Study Comparing Ampicillin and Placebo. Am J Dis Child 124:554-5611
61. Kazemi M, Gumpert TG, Marks MI (1973) A controlled trial comparing sulfametboxazole-trimethoprim, ampicillin, and no therapy in the treatment of salmonella gastroenteritis in children. J Pediatr 83:646-6500
62. Macdonald WB, Friday F, McEacharn M (1954) The Effect of Chloramphenicol in Salmonella Enteritis of Infancy. Arch Dis Child 29:238-2411
63. Geme JW, 3rd, Hodes HL, Marcy SM, Pickering LK, Rodriguez WJ, McCracken GH, Jr. et al (1988) Consensus: Management of Salmonella infection in the first year of life. Pediatr Infect Dis J 7:615-6211
64. Voltersvik P, Halstensen A, Langeland N, Digranes A, Peterson LE, Rolstad T et al (2000) Eradication of non-typhoid salmonellae in acute enteritis after therapy with ofloxacin for 5 or 10 days. J Antimicrob Chemother 46:457-4599
65. Stoycheva MV, Murdjeva MA (2006) Antimicrobial therapy of salmonelloses-current state and perspectives. Folia Med (Plovdiv) 48:5-100
66. Tsai MH, Huang YC, Lin TY, Huang YL, Kuo CC, Chiu CH (2011) Reappraisal of parenteral antimicrobial therapy for nontyphoidal Salmonella enteric infection in children. Clin Microbiol Infect 17:300-3055
67. Onwuezobe IA, Oshun PO (2008) Antbiotics for treating nontyphoidal Salmonella diarrhoea. Cochrane Database Syst. Rev
68. Sirinavin S, Thavornnunth J, Sakchainanont B, Bangtrakulnonth A, Chongthawonsatid S, Junumporn S (2003) Norfloxacin and azithromycin for treatment of nontyphoidal salmonella carriers. Clin Infect Dis 37:685-6911
69. Zavala Trujillo I, Quiroz C, Gutierrez MA, Arias J, Renteria M (1991) Fluoroquinolones in the treatment of typhoid fever and the carrier state. Eur J Clin Microbiol Infect Dis 10:334-3411
70. Nelson MR, Shanson DC, Hawkins DA, Gazzard BG (1992) Salmonella, Campylobacter and Shigella in HIV-seropositive patients. AIDS (London, England) 6:1495-14988
71. Kaplan JE, Benson C, Holmes KH, Brooks JT, Pau A, Masur H et al (2009) Guidelines for prevention and treatment of opportunistic infections in HIVinfected adults and adolescents: Recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep 58:1-207, (quiz CE1-4) \\
72. Roberts C, Wilkins EG (1987) Salmonella screening of pregnant women. J Hosp Infect 10:67-722
73. Schloesser RL, Schaefer V, Groll AH (2004) Fatal transplacental infection with non-typhoidal Salmonella. Scand J Infect Dis 36:773-7744
74. Cooke FJ, Ginwalla S, Hampton MD, Wain J, Ross-Russell R, Lever A et al (2009) Report of neonatal meningitis due to Salmonella enterica serotype Agona and review of breast milk-associated neonatal Salmonella infections. J Clin Microbiol 47:3045-30499
75. Cahill SM, Wachsmuth K, Costarrica M, Embarek P (2008) Powdered Infant Formula as a Source of Salmonella Infection in Infants. Clin Infect Dis 46:268-2733
76. Van Der Klooster JM, Roelofs HJ (1997) Management of Salmonella infections during pregnancy and puerperium. Neth J Med 51:83-866
77. Varma JK, Molbak K, Barrett TJ, Beebe JL, Jones TF, Rabatsky-Ehr T et al (2005) Antimicrobial-resistant nontyphoidal Salmonella is associated with excess bloodstream infections and hospitalizations. J Infect Dis 191:554-5611
78. Su L-H, Chiu C-H, Chu C, Ou JT (2004) Antimicrobial resistance in nontyphoid Salmonella serotypes: A global challenge. Clin Infect Dis 39:546-5511
79. Parry CM, Threlfall EJ (2008) Antimicrobial resistance in typhoidal and nontyphoidal salmonellae. Curr Opin Infect Dis 21:531-5388
80. Angulo FJ, Johnson KR, Tauxe RV, Cohen ML (2000) Origins and consequences of antimicrobialresistant nontyphoidal Salmonella: Implications for the use of fluoroquinolones in food animals. Microb Drug Resist (Larchmont, NY) 6:77-833
81. Crump JA, Medalla FM, Joyce KW, Krueger AL, Hoekstra RM, Whichard JM et al (2011) Antimicrobial resistance among invasive nontyphoidal Salmonella enterica isolates in the United States: National Antimicrobial Resistance Monitoring System, 1996-2007. Antimicrob Agents Chemother 55:1148-11544
82. Meakins S, Fisher IST, Berghold C, Gerner-Smidt P, Tschape H, Cormican M et al (2008) Antimicrobial drug resistance in human nontyphoidal Salmonella isolates in Europe 2000-2004: A report from the Enter-net International Surveillance Network. Microb Drug Resist (Larchmont, NY) 14:31-355
83. Reddy EA, Shaw AV, Crump JA (2010) Communityacquired bloodstream infections in Africa: A systematic review and meta-analysis. Lancet Infect Dis 10:417-4322
84. Nordmann P, Poirel L, Mak JK, White PA, McIver CJ, Taylor P (2008) Multidrug-resistant Salmonella strains expressing emerging antibiotic resistance determinants. Clin Infect Dis 46:324-3255
85. Miriagou V, Tzouvelekis LS, Rossiter S, Tzelepi E, Angulo FJ, Whichard JM (2003) Imipenem resistance in a Salmonella clinical strain due to plasmid-mediated class A carbapenemase KPC-2. Antimicrob Agents Chemother 47:1297-13000
86. Hakanen A, Kotilainen P, Jalava J, Siitonen A, Huovinen P (1999) Detection of decreased fluoroquinolone susceptibility in Salmonellas and validation of nalidixic acid screening test. J Clin Microbiol 37:3572-35777
87. Hakanen AJ, Lindgren M, Huovinen P, Jalava J, Siitonen A, Kotilainen P (2005) New quinolone resistance phenomenon in Salmonella enterica: Nalidixic acid-susceptible isolates with reduced fluoroquinolone susceptibility. J Clin Microbiol 43:5775-57788
88. Chorba TL, Meriwether RA, Jenkins BR, Gunn RA, MacCormack JN (1987) Control of a non-foodborne outbreak of salmonellosis: Day care in isolation. Am J Public Health 77:979-9811
89. Tauxe RV, Hassan LF, Findeisen KO, Sharrar RG, Blake PA (1988) Salmonellosis in nurses: Lack of transmission to patients. J Infect Dis 157:370-3733
90. (1987) Food handlers and salmonella food poisoning Lancet 2:606-6077
91. Kassis I, Dagan R, Chipman M, Alkan M, Simo A, Gorodischer R (1990) The use of prophylactic furazolidone to control a nosocomial epidemic of multiply resistant Salmonella typhimurium in pediatric wards. Pediatr Infect Dis J 9:551-5555
92. Dyson C, Ribeiro CD, Westmoreland D (1995) Large scale use of ciprofloxacin in the control of a Salmonella outbreak in a hospital for the mentally handicapped. J Hosp Infect 29:287-2966
93. Linnemann CC, Jr., Cannon CG, Staneck JL, McNeely BL (1985) Prolonged hospital epidemic of salmonellosis: Use of trimethoprim-sulfamethoxazole for control. Infection control: IC 6:221-2255
94. Siegel JD, Rhinehart E, Jackson M, Chiarello L (2007) Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings. Healthcare Infection Control Practices Advisory Committee (HICPAC) \\
95. NHMRC (2010) Australian Guidelines for the Prevention and Control of Infection in Healthcare. Commonwealth of Australia 1-2622